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Background
The beta lactam antibiotics are predominant therapeutic
agents against a number of infectious diseases. The pro-
duction of the enzyme beta lactamase by microbes
which hydrolyses the beta lactam antibiotics is an
important mechanism of resistance. This study aimed to
determine prevalence, phenotypic patterns, and ESBL-
production status both phenotypic and genotypic for the
CTX –M type ESBL in Escherichia coli (E.coli) isolated
from Diarrhoeic children.
Methods
Two hundred thirty non repetitive stool samples were
collected from 2 hospitals, one private and other govern-
ment hospital in Delhi, NCR. E.coli was confirmed by
16S rRNA analyses. Antibiotic susceptibility and pheno-
typic ESBL production were studied by disc diffusion and
double disk synergy tests according to Clinical Labora-
tory Standards Institute guidelines. PCR was performed
for the molecular detection of the CTX-M type ESBL.
Results
Out of 230, 215 were confirmed to be E.coli. Phenotypically
72.5% (156) showed the presence of ESBL of which 75%
(79) in private hospital samples and 70% (77) in govern-
ment hospital samples. PCR based molecular detection
confirmed the presence of the CTX-M gene among
65.6% (141) of the samples.
Conclusion
The high trends in the ESBL presence are alarming
and urge means to cope with such ESBL E.coli strains.
It being a commensal raises concern of the resistance
gene transfer from pathogenic bacteria, especially in
children due to common diarrhoeal episodes among
them. The paediatric population is at a higher risk in
case of multidrug resistance due to further limitation in
therapeutic options and constrains in prescription of
harsher antibiotics.
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